These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1294434)

  • 1. [Monitoring daily insulin needs--an important follow-up parameter in late pregnancy in diabetic mothers?].
    Fasching P; Kainz C; Damjancic P; Endler M; Schneider B; Kurzemann S; Vierhapper H; Waldhäusl W
    Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):596-601. PubMed ID: 1294434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of growth hormone and human placental lactogen in pregnancy complicated by diabetes.
    Lopez-Espinoza I; Smith RF; Gillmer M; Schidlmeir A; Hockaday TD
    Diabetes Res; 1986 Mar; 3(3):119-25. PubMed ID: 3519044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining insulin requirement in the late first trimester of diabetic pregnancy.
    Jovanovic L; Knopp RH; Brown Z; Conley MR; Park E; Mills JL; Metzger BE; Aarons JH; Holmes LB; Simpson JL;
    Diabetes Care; 2001 Jul; 24(7):1130-6. PubMed ID: 11423491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect, on the newborn infant, of carbohydrate metabolism in pregnancy in insulin-dependent diabetics].
    Reiher H; Fuhrmann K; Semmler K; Jutzi E; Besch W; Hahn HJ
    Zentralbl Gynakol; 1984; 106(8):524-9. PubMed ID: 6375209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal growth in women managed with insulin pump therapy compared to conventional insulin.
    Kernaghan D; Farrell T; Hammond P; Owen P
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):47-9. PubMed ID: 18006209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
    Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
    Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Preexisting Diabetes in Pregnancy.
    Padmanabhan S; Lee VW; Mclean M; Athayde N; Lanzarone V; Khoshnow Q; Peek MJ; Cheung NW
    Diabetes Care; 2017 Oct; 40(10):1323-1330. PubMed ID: 28798085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional insulin therapy and pregnancy].
    Fasching P
    Wien Med Wochenschr; 1997; 147(9):217-21. PubMed ID: 9281235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing fetal growth in infants of diabetic mothers.
    MacGillivray MH
    J Pediatr Gastroenterol Nutr; 1983; 2 Suppl 1():S73-80. PubMed ID: 6358448
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modular education in diabetes and pregnancy: analysis of results of 58 pregnancies in diabetic patients with functional insulin treatment].
    Howorka K; Pumprla J; Feiks A; Schlusche C; Nowotny C; Ulm M; Schober E; Bernaschek G
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):41-9. PubMed ID: 8852785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin-dependent diabetes and pregnancy. A model of coordinated approach].
    Gamba S; Barolo P; Blatto A; Grassi G; Carlini M; Winkler T; Zanno C; Bianciotto F; Guala G; Gandolfo MT
    Ann Osp Maria Vittoria Torino; 1986; 29(1-6):127-64. PubMed ID: 3324885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
    Hauffe F; Schaefer-Graf UM; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M
    Diabet Med; 2019 Feb; 36(2):158-166. PubMed ID: 30698863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
    Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
    Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy.
    Gómez AM; Marín Carrillo LF; Arévalo Correa CM; Muñoz Velandia OM; Rondón Sepúlveda MA; Silva Herrera JL; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Jul; 19(7):417-422. PubMed ID: 28731823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case-control study.
    Volpe L; Pancani F; Aragona M; Lencioni C; Battini L; Ghio A; Resi V; Bertolotto A; Del Prato S; Di Cianni G
    Gynecol Endocrinol; 2010 Mar; 26(3):193-6. PubMed ID: 19728190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: An interim analysis from a longitudinal mother-child cohort study.
    Gomes D; von Kries R; Delius M; Mansmann U; Nast M; Stubert M; Langhammer L; Haas NA; Netz H; Obermeier V; Kuhle S; Holdt LM; Teupser D; Hasbargen U; Roscher AA; Ensenauer R
    PLoS Med; 2018 Oct; 15(10):e1002681. PubMed ID: 30372451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes.
    Fuglsang J; Lauszus F; Flyvbjerg A; Ovesen P
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4355-61. PubMed ID: 12970310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes.
    Fuglsang J; Lauszus F; Flyvbjerg A; Ovesen P
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4355-61. PubMed ID: 14557493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.